Clinical Trial Update: Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial conducted at University Hospital, Toulouse, evaluating amantadine for L-DOPA-induced dyskinesia in early Parkinson's disease has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• amantadine (amantadine)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED